These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 23244668)

  • 1. Biologic activity of the novel small molecule STAT3 inhibitor LLL12 against canine osteosarcoma cell lines.
    Couto JI; Bear MD; Lin J; Pennel M; Kulp SK; Kisseberth WC; London CA
    BMC Vet Res; 2012 Dec; 8():244. PubMed ID: 23244668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI; Liu A; Lin L; Wei CC; Schwartz EB; Bhasin D; Li C; Fuchs JR; Li PK; Houghton P; Termuhlen A; Gross T; Lin J
    Invest New Drugs; 2012 Jun; 30(3):916-26. PubMed ID: 21340507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L; Hutzen B; Li PK; Ball S; Zuo M; DeAngelis S; Foust E; Sobo M; Friedman L; Bhasin D; Cen L; Li C; Lin J
    Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of STAT3 activation and expression in canine and human osteosarcoma.
    Fossey SL; Liao AT; McCleese JK; Bear MD; Lin J; Li PK; Kisseberth WC; London CA
    BMC Cancer; 2009 Mar; 9():81. PubMed ID: 19284568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-angiogenic activity of a small molecule STAT3 inhibitor LLL12.
    Bid HK; Oswald D; Li C; London CA; Lin J; Houghton PJ
    PLoS One; 2012; 7(4):e35513. PubMed ID: 22530037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LLL12, a novel small inhibitor targeting STAT3 for hepatocellular carcinoma therapy.
    Zuo M; Li C; Lin J; Javle M
    Oncotarget; 2015 May; 6(13):10940-9. PubMed ID: 25883212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small molecule, LLL12 inhibits constitutive STAT3 and IL-6-induced STAT3 signaling and exhibits potent growth suppressive activity in human multiple myeloma cells.
    Lin L; Benson DM; DeAngelis S; Bakan CE; Li PK; Li C; Lin J
    Int J Cancer; 2012 Mar; 130(6):1459-69. PubMed ID: 21520044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small molecule, LLL12, inhibits STAT3 phosphorylation and induces apoptosis in medulloblastoma and glioblastoma cells.
    Ball S; Li C; Li PK; Lin J
    PLoS One; 2011 Apr; 6(4):e18820. PubMed ID: 21526200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A small molecule STAT3 inhibitor, LLL12, enhances cisplatin‑ and paclitaxel‑mediated inhibition of cell growth and migration in human ovarian cancer cells.
    Zhang R; Chen X; Fu S; Xu L; Lin J
    Oncol Rep; 2020 Sep; 44(3):1224-1232. PubMed ID: 32705214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of STAT3 expression, signaling and inhibition in feline oral squamous cell carcinoma.
    Brown ME; Bear MD; Rosol TJ; Premanandan C; Kisseberth WC; London CA
    BMC Vet Res; 2015 Aug; 11():206. PubMed ID: 26272737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterizing the metabolic role of STAT3 in canine osteosarcoma.
    Gardner HL; Fenger JM; Roberts RD; London CA
    Vet Comp Oncol; 2022 Dec; 20(4):817-824. PubMed ID: 35608271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel HSP90 inhibitor STA-1474 exhibits biologic activity against osteosarcoma cell lines.
    McCleese JK; Bear MD; Fossey SL; Mihalek RM; Foley KP; Ying W; Barsoum J; London CA
    Int J Cancer; 2009 Dec; 125(12):2792-801. PubMed ID: 19544563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncostatin M promotes STAT3 activation, VEGF production, and invasion in osteosarcoma cell lines.
    Fossey SL; Bear MD; Kisseberth WC; Pennell M; London CA
    BMC Cancer; 2011 Apr; 11():125. PubMed ID: 21481226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. YM155 enhances the cytotoxic activity of etoposide against canine osteosarcoma cells.
    Ong SM; Saeki K; Kok MK; Nakagawa T; Nishimura R
    J Vet Med Sci; 2019 Aug; 81(8):1182-1190. PubMed ID: 31308291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of STAT3 inhibition on survival of osteosarcoma cell lines.
    Wang X; Goldstein D; Crowe PJ; Yang JL
    Anticancer Res; 2014 Nov; 34(11):6537-45. PubMed ID: 25368256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T; Asanuma K; Matsumine A; Matsubara T; Nakamura T; Iino T; Asanuma Y; Goto M; Okuno K; Kakimoto T; Yada Y; Sudo A
    Int J Oncol; 2016 Dec; 49(6):2275-2284. PubMed ID: 27840900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two small molecule compounds, LLL12 and FLLL32, exhibit potent inhibitory activity on STAT3 in human rhabdomyosarcoma cells.
    Wei CC; Ball S; Lin L; Liu A; Fuchs JR; Li PK; Li C; Lin J
    Int J Oncol; 2011 Jan; 38(1):279-85. PubMed ID: 21109950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
    Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
    BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oleanane triterpenoid CDDO-Me induces apoptosis in multidrug resistant osteosarcoma cells through inhibition of Stat3 pathway.
    Ryu K; Susa M; Choy E; Yang C; Hornicek FJ; Mankin HJ; Duan Z
    BMC Cancer; 2010 May; 10():187. PubMed ID: 20459702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The interaction between RUNX2 and core binding factor beta as a potential therapeutic target in canine osteosarcoma.
    Alegre F; Ormonde AR; Godinez DR; Illendula A; Bushweller JH; Wittenburg LA
    Vet Comp Oncol; 2020 Mar; 18(1):52-63. PubMed ID: 31381810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.